Rao, Deepak

Deepak A. Rao is a researcher in the field of immunology and nephrology. He has contributed to various studies on lupus nephritis, focusing on single-cell analysis of kidney samples to understand the immune cell landscape and identify potential targets for treatment. His work has been published in reputed scientific journals such as Nature.

Biography:  https://www.nature.com/articles/s41590-019-0398-x

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

New Insights into the Role of AHR in Regulating T Cell CXCL13 Production and Potential Therapeutic Strategies for Systemic Lupus Erythematosus

New Insights into the Role of AHR in Regulating T Cell CXCL13 Production and Potential Therapeutic Strategies for Systemic Lupus Erythematosus

Broke On: Wednesday, 10 July 2024 New research reveals the role of the aryl hydrocarbon receptor (AHR) in regulating T cell production of CXCL13, a key chemoattractant for B cells in systemic lupus erythematosus (SLE). An imbalance between PD-1/ICOS CXCL13+ T cells and CD96hi IL-22+ T cells contributes to SLE pathology. Insufficient AHR activation leads to excess disease-causing T peripheral helper cells, while activating the AHR pathway or limiting interferon could potentially cure lupus.